Functional and Immunohistochemical Characterization of CB1 and CB2 Receptors in Rat Bladder

Urology

Volumn 72, Issue 5, 2008, Pages 1174-1178

  Hayn, Matthew H ^a   Ballesteros, Inmaculada ^a   de Miguel, Fernando ^a   Coyle, Christian H ^a   Tyagi, Shachi ^a   Yoshimura, Naoki ^a   Chancellor, Michael B ^a   Tyagi, Pradeep ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ADENOSINE TRIPHOSPHATE; AJULEMIC ACID; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CAPSAICIN;

ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENE LOCATION; HORMONE RELEASE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; UROTHELIUM;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; INDOLES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; TETRAHYDROCANNABINOL; TISSUE CULTURE TECHNIQUES; URINARY BLADDER;

EID: 54449085008     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.03.044     Document Type: Article

References (23)

1. Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 105 (2006) 1-25
2. Costa B., Siniscalco D., Trovato A.E., et al. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol. 148 (2006) 1022-1032
3. Chancellor M.B., and Yoshimura N. Treatment of interstitial cystitis. Urology 63 (2004) 85-92
4. Freeman R.M., Adekanmi O., Waterfield M.R., et al. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct. 17 6 (2006) 636-641
5. Howlett A.C., Barth F., Bonner T.I., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 54 (2002) 161-202
6. Cabral G.A. Localization of cannabinoid receptors using immunoperoxidase methods. Methods Mol Med. 123 (2006) 41-69
7. Facci L., Dal Toso R., Romanello S., et al. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A 92 (1995) 3376-3380
8. Onaivi E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54 (2006) 231-246
9. Helyes Z., Nemeth J., Than M., et al. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. Life Sci. 73 (2003) 2345-2353
10. Martin R.S., Luong L.A., Welsh N.J., et al. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br J Pharmacol. 129 (2000) 1707-1715
11. Pertwee R.G., and Fernando S.R. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol. 118 (1996) 2053-2058
12. Rapp D.E., Turk K.W., Bales G.T., et al. Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol. 175 (2006) 1138-1142
13. Dyson A., Peacock M., Chen A., et al. Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat. Pain 116 (2005) 129-137
14. Hiragata S., Ogawa T., Hayashi Y., et al. Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology 70 (2007) 202-208
15. Karst M., Salim K., Burstein S., et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA 290 (2003) 1757-1762
16. Yesilyurt O., and Dogrul A. Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice. Neurosci Lett. 371 (2004) 122-127
17. Jaggar S.I., Hasnie F.S., Sellaturay S., et al. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76 (1998) 189-199
18. Aguado T., Palazuelos J., Monory K., et al. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci. 26 (2006) 1551-1561
19. Gabella G. Structure of the intramural nerves of the rat bladder. J Neurocytol. 28 (1999) 615-637
20. Avelino A., Cruz C., Nagy I., et al. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109 (2002) 787-798
21. Dinis P., Charrua A., Avelino A., et al. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci. 24 (2004) 11253-11263
22. Fride E., Foox A., Rosenberg E., et al. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. Eur J Pharmacol. 461 (2003) 27-34
23. Veale E.L., Buswell R., Clarke C.E., et al. Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide. Br J Pharmacol. 152 (2007) 778-786